Targeting Intraocular Neovascularization and Edema — One Drop at a Time  

Oleh:

Aiello, Lloyd Paul

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: The New England Journal of Medicine (keterangan: ada di Proquest) vol. 359 no. 09 (Aug. 2008), page 967.

Ketersediaan

Perpustakaan FK Nomor Panggil: N08.K.2008.04 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

Barring death, blindness is one of the most feared complications of human disease. In developed countries worldwide, the vast majority of visual loss results from pathologic neovascularization of the choroid and retina or retinal edema, conditions that are thought to be mediated primarily by the angiogenic and vasopermeability molecule called vascular endothelial growth factor (VEGF). These complications are treated with either laser photocoagulation, which destroys areas of otherwise functional retina, or antiangiogenic agents that are repeatedly injected into the center of the eye. Recent studies by Scheppke et al.1 and Doukas et al.2 indicate that a different approach may be . . .

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali